Mary Ann Clark

3.9k total citations · 1 hit paper
88 papers, 2.4k citations indexed

About

Mary Ann Clark is a scholar working on Education, Social Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mary Ann Clark has authored 88 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Education, 16 papers in Social Psychology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mary Ann Clark's work include Counseling Practices and Supervision (12 papers), Parental Involvement in Education (8 papers) and Educational and Psychological Assessments (8 papers). Mary Ann Clark is often cited by papers focused on Counseling Practices and Supervision (12 papers), Parental Involvement in Education (8 papers) and Educational and Psychological Assessments (8 papers). Mary Ann Clark collaborates with scholars based in United States, United Kingdom and New Zealand. Mary Ann Clark's co-authors include Ellen S. Amatea, Robert Cody, John H. Laragh, Andrew B. Covit, Carolyn Stone, S H Kubo, Alex Shaknovich, Steven A. Atlas, Maria Jose F. Camargo and David Tirschwell and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mary Ann Clark

82 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.

1986 571 citations Robert Cody, John H. Laragh et al. profile →

Peers

Countries citing papers authored by Mary Ann Clark

Since Specialization

Citations

This map shows the geographic impact of Mary Ann Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Clark more than expected).

Fields of papers citing papers by Mary Ann Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Clark. The network helps show where Mary Ann Clark may publish in the future.

Co-authorship network of co-authors of Mary Ann Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Clark. A scholar is included among the top collaborators of Mary Ann Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Clark. Mary Ann Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells 2022 ·Transplantation and Cellular Therapy ·Ibrahim Aldoss, Samer K. Khaled, M. Suzette Blanchard, Xiuli Wang, Jamie R. Wagner, Mary Ann Clark, Jennifer Simpson, Jinny Paul, Anthony S. Stein, Vinod Pullarkat, Amandeep Salhotra, Monzr M. Al Malki, Sandra P. Thomas, Lihua E. Budde, Guido Marcucci, Christine E. Brown, Stephen J. Forman	1
2	Support for Students who have Experienced Bullying Because of their Race or Ethnicity 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Mary Ann Clark, Vanessa A. Green	1
3	Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments 2022 ·Clinical and Translational Radiation Oncology ·Michael D. Chuong, Mary Ann Clark, Lauren E. Henke, Amar U. Kishan, Lorraine Portelance, Parag J. Parikh, M. Bassetti, Himanshu Nagar, Stephen A. Rosenberg, Minesh P. Mehta, Tamer Refaat, Justin Rineer, Adam Smith, Steven K. Seung, (unknown), Martin Fuß, Raymond H. Mak	12
4	Patterns of Utilization and Clinical Adoption of 0.35 MR-Guided Radiation Therapy in the United States — Understanding the Transition to Adaptive, Ultra-Hypofractionated Treatments 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Michael D. Chuong, Mary Ann Clark, Lauren E. Henke, Amar U. Kishan, Lorraine Portelance, Parag J. Parikh, Himanshu Nagar, Stephen A. Rosenberg, Minesh P. Mehta, (unknown), Adam J. T. Smith, Steven K. Seung, Bassem I. Zaki, Raymond H. Mak	4
5	FIVE-YEAR CLINICAL AND ECONOMIC OUTCOMES IN PATIENTS WITH MEDICALLY MANAGED SEVERE AORTIC STENOSIS: RESULTS FROM A MEDICARE CLAIMS ANALYSIS 2011 ·Journal of the American College of Cardiology ·Mary Ann Clark, Francis G. Duhay, Ann Thompson, Michelle J. Keyes, Lars G. Svensson, Robert O. Bonow, (unknown), David J. Cohen	1
6	Rechargeable Spinal Cord Stimulation Versus Nonrechargeable System for Patients With Failed Back Surgery Syndrome: A Cost-Consequences Analysis 2008 ·Clinical Journal of Pain ·John Hornberger, Krishna Kumar, (unknown), Mary Ann Clark, John Hernandez	56
7	Joining Forces: Building Collaborative Learning Communities through Family-School-University-Community Partnerships 2006 ·Journal of higher education outreach & engagement ·Mary Ann Clark, Ellen S. Amatea	1
8	Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization 2006 ·Journal of the American College of Cardiology ·Ameet Bakhai, Gregg W. Stone, Elizabeth M. Mahoney, Tara A. Lavelle, Chunxue Shi, Ronna H. Berezin, Betsy J. Lahue, Mary Ann Clark, Michael J. Lacey, Mary E. Russell, Stephen G. Ellis, James Hermiller, David A. Cox, David J. Cohen	53
9	Teacher Perceptions and Expectations of School Counselor Contributions: Implications for Program Planning and Training. 2004 ·Professional School Counseling ·Mary Ann Clark, Ellen S. Amatea	47
10	Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents 2004 ·BMC Cardiovascular Disorders ·Michael T. Halpern, Michael J. Lacey, Mary Ann Clark, (unknown)	2
11	Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issues 2004 ·Catheterization and Cardiovascular Interventions ·John McB. Hodgson, Randy K. Bottner, Lloyd W. Klein, (unknown), David J. Cohen, Donald E. Cutlip, Randolph B. Fenninger, Brian G. Firth, Dan Greenberg, (unknown), (unknown), Wayne Powell, Gregg W. Stone, (unknown), Mary Ann Clark	42
12	The impact of diabetes on clinical and economic outcomes of percutaneous coronary intervention in the elderly: A population-based analysis 2003 ·Journal of the American College of Cardiology ·Ameet Bakhai, Mary Ann Clark, (unknown), Elise M. Pelletier, David J. Cohen, (unknown)	0
13	Left hemispheric specialization for learned, skilled, and purposeful action. 1998 ·Neuropsychology ·Howard Poizner, Alma S. Merians, Mary Ann Clark, Beth Macauley, Leslie J. Gonzalez Rothi, K. M. Heilman	31
14	Sensory loss of the distal phalanx caused by pulse oximeter probe 1997 ·Anaesthesia ·Mary Ann Clark, (unknown)	2
15	Spatial Planning deficits in limb apraxia 1994 ·Brain ·Mary Ann Clark, Alma S. Merians, (unknown), Howard Poizner, Beth Macauley, Leslie J. Gonzalez Rothi, K. M. Heilman	105
16	Sustained‐release (+)‐PHNO [MK‐458 (HPMC)] in the treatment of Parkinson's disease: Evidence for tolerance to a selective D₂‐receptor agonist administered as a long‐acting formulation 1990 ·Movement Disorders ·Jesse M. Cedarbaum, Mary Ann Clark, (unknown), (unknown)	14
17	L-Deprenyl, Levodopa Pharmacokinetics, and Response Fluctuations in Parkinsonʼs Disease 1990 ·Clinical Neuropharmacology ·Jesse M. Cedarbaum, (unknown), Mary Ann Clark, (unknown), Henn Kutt	22
18	Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR) 1990 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Jesse M. Cedarbaum, (unknown), Mary Ann Clark, (unknown), (unknown), (unknown), Fletcher McDowell	5
19	Regulation of glomerular filtration rate in chronic congestive heart failure patients 1988 ·Kidney International ·Robert Cody, Susanne Ljungman, Andrew B. Covit, Spencer H. Kubo, Jean E. Sealey, (unknown), Mary Ann Clark, Gary D. James, John H. Laragh	108
20	MCABS OF THERAPEUTIC POTENTIAL WHICH INTERACT WITH HOST EFFECTOR SYSTEMS 1984 ·British Journal of Cancer ·Mary Ann Clark, Stephen Cobbold, G Hale, Herman Waldmann	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact